Skip to content
Search

Latest Stories

England sees a ‘catastrophic rise’ in alcohol deaths

AHA urges the health secretary to make addressing alcohol harm his New Year’s resolution
gettyimages

AHA urges the health secretary to make addressing alcohol harm his New Year’s resolution

Public health experts are calling for a stronger, comprehensive government intervention to tackle the escalating levels of alcohol-related harm in England, as new data reveals a significant rise in alcohol deaths.

Official figures indicate a “catastrophic rise” in alcohol-related deaths, with 8,274 people dying in 2023 alone—a 42% increase since 2019.


Official figures indicate a “catastrophic rise” in deaths caused solely by alcohol, with 8,274 people dying in 2023 alone—a 42 per cent increase since 2019.

The North East recorded the highest mortality rates, more than double those in London.

The Alcohol Health Alliance (AHA), which represents 60 organisations working to reduce alcohol-related harm, has warned that this number represents only the tip of the iceberg as it reflects deaths wholly attributable to alcohol.

When cases where alcohol was a contributing factor are considered, the death toll could triple the current estimates, they said.

In a letter to health secretary Wes Streeting, AHA members urged him to prioritise addressing this alarming trend as his New Year’s resolution and stop the “needless suffering of countless individuals, their children, families and communities across the country.”

Professor Sir Ian Gilmore, chair of the AHA, said: “Alcohol-related harm does not occur in isolation. It ripples through families, often leaving children to bear the brunt of grief and trauma.

“The devastating rise in alcohol deaths should serve as an alarm for the new government to act with urgency.”

The AHA highlighted the widespread impact of alcohol on public health, citing almost 950,000 alcohol-related hospital admissions annually, representing six per cent of all hospitalisations.

“Not only is alcohol linked to seven types of cancer and cardiovascular disease, it also plays a significant role in poor mental health, with 70 per cent of those in alcohol treatment also reporting a mental health need.”

The financial toll is equally stark, with alcohol costing the NHS an estimated £4.91 billion each year.

The letter also underscored significant disparities in alcohol harm across England, with hospitalisations and deaths disproportionately affecting the most deprived communities.

To address this crisis, the AHA proposed implementing effective policies, such as minimum unit pricing (MUP), as in Scotland.

They also called for leveraging the Health Mission board to mobilise cross-government action and for the NHS 10-year plan to prioritize strengthening the health service response to alcohol harm.

The Medical Council on Alcohol’s recommendations were also endorsed, including enhanced funding for alcohol care teams, improved access to community-based alcohol services, and better integration of care pathways.

Furthermore, they stressed the need for the adoption of policies that tackle the affordability, availability, and marketing of alcohol, as outlined in the AHA’s manifesto.

“Without bold, decisive action, these preventable deaths will continue to climb,” Professor Gilmore stated.

“Addressing alcohol harm must be a top public health priority in 2025, and it requires a cross-government effort to turn the tide on this public health crisis,” he added.

The experts also highlighted the broader benefits of reducing alcohol consumption, which could support other health priorities like smoking cessation and weight management. Alcohol is also a key driver of crime, including domestic violence.

They cautioned that, if left unchecked, the alcohol harm crisis will only escalate further, placing an ever-greater burden on our healthcare system, economy and society.

“We know what works, and now is the time to act,” the letter concluded.

Official Statistics reveal that around 3,800 individuals in England and Wales were fitted with an alcohol monitoring device at the end of November 2024, an increase of about 1,000 compared to the figure recorded at the end of December 2023.

More For You

Omega Pharmacy in Derbyshire Finds New Owner in Just 18 Days

Omega Pharmacy

Christie & Co

Omega Pharmacy in Derbyshire sold in just 18 days

Omega Pharmacy in Derbyshire has found a new owner in less than three weeks after being put on the market.

The pharmacy was previously owned by husband-and-wife duo Manny and Poonam Rai, who decided to sell it after a short period of ownership to focus on their other pharmacy in Coventry, according to Christie & Co.

Keep ReadingShow less
DHSC announces second list of March 2025 price concessions

A price concession only applies for the month it is granted.

Getty Images

March price concessions list released; prescription charge remains unchanged

The Department of Health and Social Care (DHSC) has released a second list of price concessions for March 2025, following ongoing discussions with Community Pharmacy England (CPE) regarding medicine pricing concerns raised by pharmacy owners.

A price concession is introduced when pharmacy contractors are unable to source a drug at or below the reimbursement price set out in the Drug Tariff.

Keep ReadingShow less
AstraZeneca partners with CEPI to develop multi-specific influenza antibody

AstraZeneca-CEPI collaboration aims to increase global access to antibody-based interventions

Getty Images

AstraZeneca secures £33M CEPI funding to develop multi-specific influenza antibody

AstraZeneca has joined forces with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance an innovative antibody technology that could help tackle future infectious disease outbreaks and pandemics swiftly and more affordably.

CEPI will provide up to US$43.5 million (£33.6 million) in funding to support the biopharmaceutical company in evaluating a type of antibody, known as a VHH (Variable Heavy domain of a Heavy chain -only antibody), through preclinical proof-of-concept studies and Phase 1 clinical trials.

Keep ReadingShow less
Community Pharmacy Patient Safety Group announces new vice-chair

Martin Sadr-Kazemi 's appointment follows the passing of Dr. José Moss in January 2025.

Martin Sadr-Kazemi appointed vice-chair of Community Pharmacy Patient Safety Group

The Community Pharmacy Patient Safety Group (CPPSG) has announced the appointment of Martin Sadr-Kazemi as its new vice-chair.

Martin, currently the medication safety officer and deputy superintendent pharmacist at Rowlands Pharmacy, has been an integral member of the CPPSG since its formation a decade ago, actively contributing to various initiatives.

Keep ReadingShow less
"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar

Pic credit: London Ambulance Service

"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar will create history when she becomes the first apprentice to become a qualified pharmacy technician through the London Ambulance Service.

Jaffar is just days away from completing her registration with the General Pharmaceutical Council.

Keep ReadingShow less